A number of documents have provided evidence for the occurrence of senescence in VSMCs during atherosclerosis, such as lower level of proliferation capacity (93), higher expression levels of p16 and p21, and decreased telomere length (94) as well as larger and flattened morphology in comparison to cells separated from healthy arterial media (95). This evidence concerns the gene CDKN2A and atherosclerosis.